Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin

Published:2007-06 Issue:6 Volume:14 Page:396-403
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Asahina Y.,Izumi N.,Umeda N.,Hosokawa T.,Ueda K.,Doi F.,Tsuchiya K.,Nakanishi H.,Matsunaga K.,Kitamura T.,Kurosaki M.,Uchihara M.,Higaki M.,Miyake S.

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2006.00803.x/fullpdf

Reference15 articles.

1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

2. Current therapy for hepatitis C: pegylated interferon and ribavirin

3. Interferon-Induced Antiviral Actions and Their Regulation

4. The Emerging Role of the Interferon-Induced PKR Protein Kinase as an Apoptotic Effector: A New Face of Death?

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term HBV infection of engineered cultures of induced pluripotent stem cell-derived hepatocytes;Hepatology Communications;2024-07-31

2. RNA protein kinase SNP at −226 C;Immunological Investigations;2018-08-06

3. Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers;BMC Pharmacology and Toxicology;2018-01-04

4. Efficacy of daclatasvir in hepatitis C virus;Expert Review of Anti-infective Therapy;2014-07-25

5. Protein kinase expression as a predictive factor for interferon response in chronic hepatitis C patients;Journal of Advanced Research;2014-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3